🕵️ Madrigal Pharmaceuticals, Inc. ($MDGL)
SEC insider & ownership activity, last 12 months · CIK 1157601 · every row links its SEC filing
Over the last 12 months insiders sold $81.5M with no open-market buying against it. Paul A. Friedman sold $26.7M through a 10b5-1 trading plan in 38 lots (Dec–Jan). 1 planned sale is pending, the largest $3.4M (William John Sibold). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 9 sellers, $81.5M (202 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Paul A. Friedman | 0 | – | 38 | $26.7M | Jan 9, 2026 |
| Taub Rebecca | 0 | – | 42 | $21.7M | Mar 6, 2026 |
| William Sibold | 0 | – | 37 | $10.5M | Sep 11, 2026 |
| Kenneth M. Bate | 0 | – | 11 | $8.0M | Nov 5, 2025 |
| Richard S. Levy | 0 | – | 26 | $7.4M | May 22, 2026 |
| Mardi Dier | 0 | – | 28 | $3.8M | Mar 6, 2026 |
| Carole Huntsman | 0 | – | 14 | $1.7M | Mar 6, 2026 |
| David Soergel | 0 | – | 2 | $952K | Jun 1, 2026 |
| Shannon Kelley | 0 | – | 4 | $842K | Aug 17, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 8.8% | 13G | May 15, 2026 | filing ↗ | |
| Rebecca TAUB, M.D. | 7.8% | 13D | Dec 10, 2025 | filing ↗ | |
| PAUL A Friedman, M.D. | 7.8% | 13D | Dec 10, 2025 | filing ↗ | |
| Paulson & Co. Inc. | 6.1% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| William Sibold | $2.8M | Sep 11, 2026 | filing ↗ |
| William John Sibold | $3.4M | Sep 9, 2026 | filing ↗ |
| Shannon Kelley | $337K | Aug 17, 2026 | filing ↗ |
| William Sibold | $1.4M | Jul 20, 2026 | filing ↗ |
| David Soergel | $518K | Jun 1, 2026 | filing ↗ |
| Richard Levy | $2.9M | May 22, 2026 | filing ↗ |
| David Soergel | $442K | May 18, 2026 | filing ↗ |
| Mardi Dier | $587K | Mar 6, 2026 | filing ↗ |
| Mardi Dier | $284K | Mar 6, 2026 | filing ↗ |
| William Sibold | $731K | Mar 6, 2026 | filing ↗ |
| Shannon Kelley | $158K | Mar 6, 2026 | filing ↗ |
| Carole Huntsman | $184K | Mar 6, 2026 | filing ↗ |
| Rebecca Taub | $216K | Mar 6, 2026 | filing ↗ |
| Mardi Dier | $511K | Mar 2, 2026 | filing ↗ |
| Carole A. Huntsman | $274K | Jan 26, 2026 | filing ↗ |
| Carole Huntsman | $163K | Jan 26, 2026 | filing ↗ |
| William Sibold | $758K | Jan 26, 2026 | filing ↗ |
| Rebecca Taub | $311K | Jan 26, 2026 | filing ↗ |
| Shannon Kelley | $215K | Jan 20, 2026 | filing ↗ |
| Shannon Kelley | $132K | Jan 20, 2026 | filing ↗ |
| Rebecca Taub | $1.1M | Jan 20, 2026 | filing ↗ |
| Rebecca A. Taub | $10.4M | Jan 9, 2026 | filing ↗ |
| Paul Friedman | $27.5M | Dec 10, 2025 | filing ↗ |
| Rebecca A. Taub | $10.3M | Dec 10, 2025 | filing ↗ |
| William John Sibold | $1.4M | Dec 4, 2025 | filing ↗ |
| Mardi C. Dier | $2.4M | Dec 2, 2025 | filing ↗ |
| Carole Huntsman | $485K | Nov 21, 2025 | filing ↗ |
| Carole Huntsman | $577K | Nov 21, 2025 | filing ↗ |
| Richard S. Levy | $4.5M | Nov 13, 2025 | filing ↗ |
| Kenneth M. Bate | $8.0M | Nov 5, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Earnings (2.02) | Jul 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 16, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 22, 2026 | filing ↗ |
| Earnings (2.02) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 5, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |